BioNTech is a biotechnology company based in Germany, primarily known for its development of immunotherapies for the treatment of cancer and its contributions to vaccine development. The company gained global recognition for its collaboration with Pfizer in creating one of the first COVID-19 vaccines using messenger RNA (mRNA) technology. Founded in 2008, BioNTech focuses on personalized medicine and aims to harness the body’s immune system to fight diseases. Its research encompasses various therapeutic areas beyond infectious diseases, including cancer immunotherapy, where it develops tailored treatments based on individual patient profiles.
BioNTech, renowned for its COVID-19 vaccine, is transitioning focus to mRNA-based cancer therapies, aiming for breakthroughs by 2026. The company experienced a decrease in profits, with EPS falling from €1.90…